B. Jonsson et al., EARLY INCREASE OF TNF-ALPHA AND IL-6 IN TRACHEOBRONCHIAL ASPIRATE FLUID INDICATOR OF SUBSEQUENT CHRONIC LUNG-DISEASE IN PRETERM INFANTS, Archives of Disease in Childhood, 77(3), 1997, pp. 198-201
Aim-To investigate if early changes in concentrations of proinflammato
ry cytokines in tracheobronchial aspirate fluid (TAF) from preterm inf
ants could be used to detect infants at risk of chronic lung disease (
CLD) and help in the selection of patients for early steroid treatment
. Methods-Twenty eight preterm infants less than 34 weeks of gestation
(median 26 weeks) were intubated and daily measurements of TAF concen
tration of tumour necrosis factor alpha (TNF alpha) and the interleuki
ns IL-1 beta, IL-6, and IL-8 were made, using enzyme immunoassay techn
iques. Results-Seventeen of the infants developed CLD. The infants who
developed CLD had significantly increased concentrations of TNF alpha
, IL-1 beta, IL-6 on days 2 and 3. TNF alpha, IL-6, and IL-8 concentra
tions were significantly related to gestational age and duration of su
pplemental oxygen; TNF alpha, IL-6, and IL-8 concentrations also corre
lated with length of time on the ventilator. Conclusion-These data ind
icate that tracheobronchial aspirate fluid cytokine concentrations may
be used as a predictor of subsequent CLD and may help select a group
of preterm infants at high risk of developing CLD for early treatment.